PubMed Health⌕ Search

Biomedical subjects

F G Shellock

Publications and source records attributed to F G Shellock.

At least 127 records · Page 7Linked to original sources

Thermal effects of high-field (1.5 tesla) magnetic resonance imaging of the spine. Clinical experience above a specific absorption rate of 0.4 W/kg.

Current safety guidelines recommend limiting the exposure to radiofrequency (RF) radiation used for clinical magnetic resonance imaging to a whole body average specific absorption rate (SAR) of 0.4 W/kg. Since it may be desirable to image with SARs that exceed this level during MRI of the spine, we evaluated the thermal responses associated with these procedures. Body and skin temperatures were determined in 25 patients immediately before and after MRI. Since the eye is particularly susceptible to thermal injury, corneal temperature was also measured. High-resolution thermography was performed on three subjects to evaluate the surface heating pattern and identify potential thermal 'hot spots'. A 1.5 tesla/64 MHz MRI system with quadrature transmission and reception was used iN this study. The whole body average specific absorption rate ranged from 0.5 to 1.3 W/kg. Ambient conditions were room temperature 20-24 degrees C and relative humidity between 40 and 50 per cent. There was a slight but statistically significant (p less than 0.01) increase in body temperature after MRI (36.5 +/- 0.4 to 36.7 +/- 0.4 degrees C). Temperatures of the hand (30.4 +/- 1.4 to 31.2 +/- 1.0 degrees C), positioning isocenter (32.1 +/- 0.6 to 32.9 +/- 0.5), and cornea (32.5 +/- 0.6 to 32.9 +/- 0.5 degrees C) also increased a statistically significant amount. Thermographic imaging revealed normal heating patterns with no surface 'hot spots'. We conclude that the temperature changes associated with MRI of the spine at the SARs we studied were well below known thresholds for adverse effects and do not appear to be harmful to patients.

Adult↗

Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.

In 14 patients with severe congestive heart failure (CHF) due to ischemic heart disease or idiopathic dilated cardiomyopathy, the hemodynamic response to intravenous infusion of dobutamine (D) was compared to that of a new non-catechol, non-glycoside, inotropic and vasodilator agent, MDL-17,043 (MDL) administered in incremental intravenous doses. D and MDL produced comparable increases in cardiac index (L/min/m2) (1.8 +/- 0.4 to 2.9 +/- 0.8 and 1.7 +/- 0.3 to 3.3 +/- 0.6, respectively; both p = 0.001) and stroke volume index (ml/beat/m2) (24 +/- 8 to 35 +/- 9 and 22 +/- 7 to 39 +/- 11, respectively; both p = 0.001). Both D and MDL reduced left ventricular filling pressure (29 +/- 5 to 24 +/- 5 and 29 +/- 6 to 17 +2- 6 mm Hg, respectively; both p less than 0.05), and mean right atrial pressure (11 +/- 4 to 8 +/- 4 and 13 +/- 5 to 6 +/- 4 mm Hg, respectively; both p = 0.001). The overall changes in heart rate and mean arterial pressure were small with both D and MDL. However, MDL in comparison to D resulted in a significantly lower left ventricular filling pressure (p = 0.001), mean pulmonary arterial pressure (p = 0.001), and mean arterial pressure (p less than 0.05). The salutary hemodynamic effects of MDL on cardiac index and left ventricular filling pressure were sustained for an average of 9.6 hours, whereas the effects of D dissipated within 30 minutes of stopping the infusion. No serious adverse effects were noted during acute administration with either drug. Therefore, intravenous MDL may be a useful substitute for D in the acute therapy of severe CHF.

Aged↗

Mixed venous blood temperature response to exercise in heart failure patients treated with short-term vasodilators.

Deep-body or core temperature decreases during exercise in patients with heart failure, primarily due to the circulatory inadequacies associated with the pathophysiology of this condition. Vasodilators are commonly used to treat patients suffering from heart failure because these drugs improve total cardiac output and blood-flow to the regional circulations. In heart failure patients, the core temperature response to exercise should also be affected if the circulation is improved by vasodilators. Patients with severe heart failure were studied at rest and during upright bicycle exercise before, and after, short-term treatment with vasodilators (2-minoxidil, 3-hydralazine, 5-captopril). Their heart rate increased significantly (P less than 0.05) from rest to exercise before (87 +/- 15 109 +/- 14 beats/min), and after 89 +/- 13- 112 +/- 15 beats/min) vasodilators, but there was no drug-related affect on these changes. Mean arterial and pulmonary capillary wedge pressures were significantly (P less than 0.05) decreased at rest and after the administration of vasodilators (mean arterial pressure 88 +/- 7 mmHg before; 77 +/- 8 mmHg after; pulmonary capillary wedge pressure 25 +/- 8 mmHg before, 19 +/- 9 mmHg after). During exercise, the increases in mean arterial and pulmonary capillary wedge pressures were not significantly different from the before vasodilator values (mean arterial pressure 92 +/- 14 mmHg before, 87 +/- 14 mmHg after; pulmonary capillary wedge pressure 31 +/- 11 mmHg before, 29 +/- 11 mmHg after). Vasodilators increased cardiac output significantly (P less than 0.05) at rest (3.1 +/- 0.6 litre/min to 4.1 +/- 1.1 litre/m) and during exercise (4.8 +/- .2 litre/min-5.6 +/- 1.7 litre/min). The core temperature (mixed venous blood temperature) decreased significantly (P less than 0.05) during exercise from 37.04 +/- 0.62 degrees C to 36.65 +/- 0.65 degrees C, before treatment with vasodilators. After administration of vasodilators, resting core temperature was not significantly different (36.95 +/- 0.54 degrees C) and still decreased significantly (P less than 0.05) during exercise to 36.73 +/- 0.53 degrees C. This decrease was significantly (P less than 0.05) different from the core temperature response before the administration of vasodilators. We conclude that heart failure patients, treated with short-term vasodilators, have an attenuation of the core temperature response that typically occurs during exercise. This change in the core temperature response is the result of the vasodilator-induced improvement in circulation.

Adult↗

Muscle and femoral vein temperatures during short-term maximal exercise in heart failure.

Core temperature decreases throughout short-term maximal exercise in heart-failure patients. To investigate possible causes for this unusual response to exercise, we studied core (pulmonary arterial blood), femoral vein, muscle, and skin temperatures in eight patients with severe heart failure who performed maximal upright incremental bicycle exercise to 50 W. A normal group (n = 4) was exercised for comparison. In the heart-failure patients, core temperature was 36.95 +/- 0.37 degrees C at rest, significantly (P less than 0.05) decreased at 25 W of exercise to 36.59 +/- 0.40 degrees C, and at 50 W remained decreased to 36.57 +/- 0.40 degrees C. In comparison, we found that the resting core temperature in the normal subjects was 37.28 +/- 0.34 degrees C, was the same at 25 W (37.29 +/- 0.41 degrees C), and increased significantly (P less than 0.05) to 37.50 +/- 0.32 degrees C at 50 W of exercise. Femoral vein temperature in heart-failure patients (n = 6) was below core temperature throughout exercise to 25 and 50 W (36.22 +/- 0.62 and 36.34 +/- 0.65 degrees C, respectively). Muscle temperature (n = 7) was significantly (P less than 0.05) lower in the heart-failure patients (34.8 +/- 1.1 degrees C) at rest compared with the normal subjects (36.2 +/- 1.0 degrees C). During exercise, muscle temperature increased above core temperature in only four of the heart-failure patients and was significantly (P less than 0.05) lower (36.5 +/- 1.3 degrees C) compared with the normal subjects (38.0 +/- 0.2 degrees C).(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

Early central venous pressure changes in the rat during two different levels of head-down suspension.

The head-down suspension (i.e. antiorthostatic hypokinesia) rat is used to simulate the circulatory effects of weightlessness. However, little is known about the early cardiovascular adaptive response to simulated weightlessness and the effects of varying degrees of head-down suspension. Therefore, the purpose of this study was to characterize the early central venous pressure changes to two different levels of head-down suspension in the rat. Unanesthetized, unrestrained, female Sprague-Dawley rats (wt: 298 +/- 18 gms, mean +/- S.D.) with chronically implanted central venous pressure catheters were subjected to either a 45 degrees C head-down tilt angle (Group A, N = 8) or a 20 degrees head-down tilt angle (Group B, N = 8) using the tail-traction technique of head-down suspension. Central venous pressure increased significantly (p less than 0.05) in both groups of rats during head-down suspension with the absolute pressure level significantly (p less than 0.05) higher in Group A rats compared to Group B rats during the first 8 h of the study. At 24 h, the rats in Group B appeared to adapt earlier to head-down suspension because central venous pressure decreased to the previous baseline level whereas it remained increased in Group A rats. We conclude that the level of head-down suspension significantly affects the early central venous pressure response and subsequent cardiovascular adaption to simulated weightlessness in rats.

Animals↗

Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.

MDL-17,043, a new inotropic drug with vasodilator properties, has been shown to produce salutary hemodynamic effects in severe heart failure, but its effects on myocardial metabolism are unknown. To determine whether such hemodynamic effects are associated with adverse effects on the myocardial oxygen demand and supply relationship, we evaluated the effects of intravenous MDL-17,043 given in incremental doses to a mean maximum dose of 2.1 mg/kg, in nine patients with severe chronic heart failure. Overall cardiac pump performance was significantly improved by MDL-17,043, as reflected by an 88% increase in stroke work index (17 +/- 11 to 32 +/- 19 gm-m/m2; p less than 0.001), a 43% reduction in left ventricular filling pressure (28 +/- 4 to 16 +/- 5 mm Hg; p less than 0.0001), a 49% reduction in systemic vascular resistance (1832 +/- 490 to 937 +/- 296 dynes-sec-cm-5; p less than 0.0001) with a slight (11%) decrease in mean arterial pressure (86 +/- 17 to 76 +/- 19 mm Hg; p = 0.005) and without significant changes in heart rate (88 +/- 14 to 91 +/- 12 bpm; p = NS). These hemodynamic effects were associated with an 18% reduction in myocardial oxygen consumption (17 +/- 5 to 14 +/- 5 ml/min p = 0.01), a 17% reduction in myocardial arteriovenous oxygen difference (13.2 +/- 2.4 to 10.9 +/- 1.8 volumes %; p = 0.01), and a 120% improvement in external myocardial efficiency (stroke work index/oxygen consumption) (1.0 +/- 0.6 to 2.2 +/- 0.9; p less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗

Temperature regulation during treadmill exercise in the rat.

The response of colonic and tail-skin temperatures to treadmill exercise was assessed in female Sprague-Dawley rats using incremental and single-stage exercise protocols to investigate the relationship between deep body temperature and work rate. O2 uptake (VO2) was measured by flow-through technique to evaluate the exercise intensity. Experiments were performed in ambient temperatures below (22-25 degrees C) and above (33-35 degrees C) the thermoneutral zone of the rat. During graded incremental exercise there was a linear relationship between colonic temperature (Tco) and VO2 in both the cooler and warmer ambient temperatures. However, Tco and tail-skin temperature (Tsk) at comparable work rates in the cooler and warmer environments were 40.22 +/- 0.59, 34.84 +/- 1.10 degrees C and 42.04 +/- 0.57, 38.39 +/- 1.54 degrees C, indicating that the rise in Tco was unrelated to the severity of exercise. During single-stage exercise the rats were able to achieve thermal equilibrium but only at low work rates and in the cool environment (22-25 degrees C). There were no significant differences in Tco at the first three levels of single-stage exercise (stage 1, 39.63 +/- 0.34 degrees C; stage 2, 39.67 +/- 0.49 degrees C; stage 3, 39.75 +/- 0.50 degrees C) despite significant differences in VO2 (stage 1, 4.3 +/- 0.7 ml X min-1 X 100 g-1; stage 2, 5.3 +/- 0.6 ml X min X 100 g-1; stage 3, 7.6 +/- 1.2 ml X min-1 X 100 g-1). This demonstrates that there was no relationship between the level of Tco maintained during exercise and the work intensity.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

Thermodilution cardiac output determination in hypothermic postcardiac surgery patients: room vs ice temperature injectate.

In normothermic patients, room temperature and ice temperature injectate have been shown to result in comparable thermodilution cardiac output measurements. However, room temperature injectate may give inaccurate results in hypothermic patients, particularly if the injectate volume is small, because of the lower injectate-to-blood temperature differential. We compared determinations of cardiac output using 10- and 5-ml volumes of room temperature (19-25 degrees C) injectate to those using 10-ml volumes of ice temperature (0-5 degrees C) injectate in 26 hypothermic (32.7 +/- 1.2 degrees C) postcardiac surgery patients. The cardiac outputs ranged from 1.8 to 5.3 L/min. Regression analysis demonstrated a close relationship between the cardiac outputs measured using room temperature injectate compared to those using ice temperature injectate (0.951 for the 10-ml volumes, 0.925 for the 5-ml volumes). We conclude that the room temperature injectate method is acceptable for determining thermodilution cardiac outputs in moderately hypothermic patients.

Adult↗

Simplified and highly accurate core temperature measurements.

A commercially available, highly accurate (+/- 0.01 degree C) thermistor catheter is described along with the feasibility of using this device to measure pulmonary artery blood temperature (core temperature) in appropriate thermoregulation studies. Intracardiac pressure monitoring, thermodilution cardiac output, and mixed venous blood sampling may also be performed with this catheter. In addition, other clinical situations which require temperature measurement such as diagnosis of malignant hyperthermia and monitoring patients after hypothermic cardiopulmonary bypass surgery may benefit from the use of this thermistor catheter.

Body Temperature↗